Grey Wolf Animal Health Insider Trading
TSX-V WOLF
1
All Trades
0
Significant
1
Notable
0
Clusters
0
Repeat
Consumer Cyclical
Sector
Personal Services
Industry
$60.0M
Market Cap
1.00 – 1.85
52 Week Range
4K
Avg. Volume
| Company | Insider | Title | Tr. Date | Fi. Date | Shares | Price | Value | Balance | Increase | Signal |
|---|---|---|---|---|---|---|---|---|---|---|
| Grey Wolf Animal Health | Palmer, Kevin | CFO | 13-Jun-25 | 16-Jun-25 | 21,000 | NT |
Related Companies to Explore
Company Info
Grey Wolf Health Corp. is a Canadian animal health and wellness company operating in two business segments: Animal Health and Pharmacy. The company sells, markets, and distributes pharmaceutical, nutraceutical, and consumable products to veterinary clinics, and also supplies pharmaceuticals for both human and animal health markets. Its animal health product portfolio includes dexmedetomidine hydrochloride oromucosal gel under the SILEO brand, sedative analgesic and reversing agents for companion animals under the SEDAJECT and ATAJECT names, and prescription drugs under the THYRO-TABS CANINE name. The company also offers a range of wound care products, including medical grade tubes, viscose net dressings, alginate dressings, absorbent foam dressings, superabsorbent dressings, and silicone perforated tapes. Its protective wear line includes pet shirts, boots, head covers, and leg sleeves sold under the medical pet shirt brand. Additional products include disposables such as syringes, needles, and IV catheters, as well as nutraceuticals and equine health products. The company was formerly known as Grey Wolf Animal Health Corp. and adopted its current name in June 2026. It is headquartered in Toronto, Canada.
Don’t miss today’s trades
Full access to real-time insider buying data — $8.25/mo, billed annually. Cancel anytime.
